A prospective study of the risk of transfusion-acquired viral infections

Transfusion Medicine

Volumn 8, Issue 3, 1998, Pages 173-178

  Murphy, E L ^a   Busch, M P ^a   Tong, M ^b   Cornett, P ^a   Vyas, G N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUNTINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

Blood transfusion; Hepatitis B virus; Hepatitis C virus; Human immunodeficiency virus; Human T lymphotropic virus types I and II

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION; CLINICAL TRIAL; COHORT ANALYSIS; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MANDATORY TESTING; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; VIRUS INFECTION;

ADULT; BLOOD TRANSFUSION; BLOOD TRANSFUSION, AUTOLOGOUS; CALIFORNIA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B VIRUS; HIV; HIV ANTIBODIES; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MALE; MANDATORY TESTING; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; VIRUS DISEASES;

EID: 0032170511     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.1998.00148.x     Document Type: Article

References (9)

1. Aach, R.D., Szmuness, W., Mosley, J.W., et al. (1981) Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients: the Transfusion-Transmitted Viruses Study. New England Journal of Medicine, 304, 989-994.
2. Alter, H.J., Purcell, R.H., Shih, J.W., et al. (1989) Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New England Journal of Medicine, 321, 1494-1500.
3. Busch, M.P., Eble, B.E., Khayam-Bashi, H., et al. (1991) Evaluation of screened blood donations for human immunodeficiency virus type 1 infection by culture and DNA amplification of pooled cells. New England Journal Medicine, 325, 1-5.
4. Centers for Disease Control. (1991) Public Health Service interagency guidelines for screening donors of blood, plasma, organs, tissues and semen for evidence of hepatitis B and hematite C. Morbidity and Mortality Weekly Report, 40, 1-17.
5. Dodd, R.Y. (1994) Adverse consequences of blood transfusion: quantitative risk estimates. In: Blood Supply: Risk, Perceptions and Prospects for the Future (ed. Nance, S.T.), Bethesda MD: American Association of Blood Banks, 1-24.
6. Donahue, J.G., Munoz, A., Ness, P.M.,. et al. (1992) The declining risk of post-transfusion hepatitis C virus infection. New England Journal of Medicine, 327, 369-373.
7. Donegan, E., Stuart, M., Niland, J.C.,. et al. (1990) Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive donation. Annals of Internal Medicine, 113, 733-739.
8. Esteve, J., Benhamou, E. & Raymond, L. (1993) Methodes statistiques en epidemiologie descriptive. Les Edns INSERM, 66.
9. Ward, J.W., Holmberg, S.D., Allen, J.R., et al. (1988) Transmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibody. New England Journal of Medicine, 318, 473-478.